Muscular Dystrophy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Muscular Dystrophy stocks.

Muscular Dystrophy Stocks Recent News

Date Stock Title
Nov 1 TVTX Travere Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Nov 1 PTCT Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug
Oct 31 TVTX Travere Therapeutics, Inc. (TVTX) Q3 2024 Earnings Call Transcript
Oct 31 SMMT Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales
Oct 31 SMMT 3 Stocks That Have Generated 1,000% Returns in Just 2 Years
Oct 31 SLDB Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
Oct 31 TVTX Travere Therapeutics beats Q3 revenue estimates
Oct 31 SMMT Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
Oct 31 TVTX Travere Therapeutics Reports Third Quarter 2024 Financial Results
Oct 31 SMMT Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight
Oct 30 TVTX A Preview Of Travere Therapeutics's Earnings
Oct 30 WVE Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
Oct 30 PTCT PTC Therapeutics resubmitted NDA for Translarna accepted by FDA
Oct 30 SMMT Summit Therapeutics Inc. (SMMT) Q3 2024 Earnings Call Transcript
Oct 30 TVTX Travere Therapeutics Q3 2024 Earnings Preview
Oct 30 PTCT PTC Therapeutics (NASDAQ:PTCT) grows 8.1% this week, taking one-year gains to 127%
Oct 30 PTCT PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
Oct 30 SMMT Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
Oct 29 WVE How to play biotech stocks: Insmed and Wave Life Sciences
Oct 29 SMMT Summit Therapeutics Q3 2024 Earnings Preview
Muscular Dystrophy

Muscular dystrophy (MD) is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time. The disorders differ in which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Many people will eventually become unable to walk. Some types are also associated with problems in other organs.The muscular dystrophy group contains thirty different genetic disorders that are usually classified into nine main categories or types. The most common type is Duchenne muscular dystrophy (DMD) which typically affects males beginning around the age of four. Other types include Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, and myotonic dystrophy. They are due to mutations in genes that are involved in making muscle proteins. This can occur due to either inheriting the defect from one's parents or the mutation occurring during early development. Disorders may be X-linked recessive, autosomal recessive, or autosomal dominant. Diagnosis often involves blood tests and genetic testing.There is no cure for muscular dystrophy. Physical therapy, braces, and corrective surgery may help with some symptoms. Assisted ventilation may be required in those with weakness of breathing muscles. Medications used include steroids to slow muscle degeneration, anticonvulsants to control seizures and some muscle activity, and immunosuppressants to delay damage to dying muscle cells. Outcomes depend on the specific type of disorder.Duchenne muscular dystrophy, which represents about half of all cases of muscular dystrophy, affects about one in 5,000 males at birth. Muscular dystrophy was first described in the 1830s by Charles Bell. The word "dystrophy" is from the Greek dys, meaning "difficult" and troph meaning "nourish". Gene therapy, as a treatment, is in the early stages of study in humans.

Browse All Tags